ClinConnect ClinConnect Logo
Search / Trial NCT06051526

The African Critical Illness Outcomes Study

Launched by UNIVERSITY OF CAPE TOWN · Sep 20, 2023

Trial Information

Current as of June 23, 2025

Completed

Keywords

ClinConnect Summary

STUDY OBJECTIVES

The objectives of this study are to determine:

1. The proportion of hospital patients who are critically ill,
2. The mortality associated with critical illness,
3. The proportion of critically ill patients who receive essential emergency and critical care,
4. The relationship between essential emergency and critical care provision, and mortality, and
5. The availability of resources necessary to provide essential emergency and critical care.

STUDY DESIGN

An African multi-centre prospective observational cohort study of adult (≥18 years) in-hospital patients. Patient fol...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • All adult patients aged 18 years or over who have been admitted for inpatient care in any department or ward in participating hospitals.
  • Exclusion Criteria:
  • None

About University Of Cape Town

The University of Cape Town (UCT) is a leading research institution in South Africa, renowned for its commitment to advancing medical science and improving public health outcomes. With a strong emphasis on innovation and interdisciplinary collaboration, UCT conducts a wide range of clinical trials aimed at addressing critical health challenges both locally and globally. The university's dedicated research teams leverage cutting-edge methodologies and ethical standards to ensure the integrity and efficacy of their studies, fostering an environment that promotes scientific excellence and enhances the understanding of various medical conditions. Through its robust partnerships with healthcare institutions and community organizations, UCT is poised to make significant contributions to the field of clinical research and the development of effective therapeutic interventions.

Locations

Khartoum, , Sudan

Patients applied

0 patients applied

Trial Officials

Tim Baker, MBChB; PhD

Principal Investigator

Muhimbili University of Health and Allied Sciences

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported